Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.
Saved in:
| Title: | Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial. |
|---|---|
| Authors: | Récher C (AUTHOR), Coiffier B (AUTHOR), Haioun C (AUTHOR), Molina TJ (AUTHOR), Fermé C (AUTHOR), Casasnovas O (AUTHOR), Thiéblemont C (AUTHOR), Bosly A (AUTHOR), Laurent G (AUTHOR), Morschhauser F (AUTHOR), Ghesquières H (AUTHOR), Jardin F (AUTHOR), Bologna S (AUTHOR), Fruchart C (AUTHOR), Corront B (AUTHOR), Gabarre J (AUTHOR), Bonnet C (AUTHOR), Janvier M (AUTHOR), Canioni D (AUTHOR), Jais JP (AUTHOR) |
| Source: | Lancet. 11/26/2011, Vol. 378 Issue 9806, p1858-1867. 10p. |
| Database: | Psychology and Behavioral Sciences Collection |
Be the first to leave a comment!
